XML 81 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash flows used in operating activities:    
Net loss $ (10,887) $ (12,634)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 896 2,004
Amortization of deferred financing costs and debt discount 550 578
Change in fair value of warrants (3,407) (2,233)
Allocation of issuance cost associated with warrants 1,233 470
Share-based compensation expense 127 355
Noncash lease expense 12 0
Loss on sale of business 6,508 0
Loss on asset disposal 0 36
Provision for doubtful accounts 0 18
Provision for excess inventory 0 463
Increases (decreases) in cash caused by changes in operating assets and liabilities:    
Accounts receivable (1,203) (173)
Inventories 259 475
Other current assets (211) 85
Other assets 263 23
Accounts payable and accrued expenses (28) (1,532)
Deferred revenues 29 73
Other long-term liabilities (47) 17
Net cash used in operating activities (5,906) (11,975)
Cash flows from (used in) investing activities:    
Purchases of property and equipment (67) (133)
Proceeds from sale of business 5,637 0
Net cash provided by (used in) investing activities 5,570 (133)
Cash flows from financing activities:    
Principal payments of long-term obligations (3,692) 0
Payment of financing lease liability (131) 0
Proceeds from sale of common stock and unit offering, net of offering cost 15,964 0
Proceeds from exercise of warrants 490 0
Proceeds from sale of common and preferred stock 0 7,234
Financial capital expenditures 0 (66)
Net cash provided by financing activities 12,631 7,168
Effect of exchange rate changes on cash and cash equivalents (4) 16
Net increase (decrease) in cash and cash equivalents 12,291 (4,924)
Cash, cash equivalents, and restricted cash at beginning of period 5,301 10,225
Cash, cash equivalents, and restricted cash at end of period 17,592 5,301
Cash paid during period for:    
Interest 1,188 1,331
Supplemental schedule of non-cash investing and financing activities:    
Proceeds from sales of business, net, paid directly to lender for principal payment of long-term obligations 3,050 0
Offering cost paid in warrants 213 0
Reclass of warrants upon exercise from liability to equity 794 0
Fair value of Convertible Preferred Stock beneficial conversion feature 554 2,487
Conversion of preferred stock into common $ 0 $ 8